Search results
Nipah monoclonal antibody to undergo human trials in India, Bangladesh in 2025
IBTmes India· 11 hours agoNipah virus, a zoonotic disease of the Paramyxovirus family, kills up to 75 per cent of the people...
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 2 days agoADA-SCiD is a rare genetic disorder marked by a severely deficient immune system...
Unveiling the mysteries: PCOD vs PCOS - Times of India
The Times of India· 1 day agoTerms like PCOD (polycystic ovary disease) and PCOS (polycystic ovarian syndrome) can make it...
What Is Lymphoma, and Is It Serious?
Verywell Health· 3 days agoHodgkin Lymphoma Treatment The goal of Hodgkin lymphoma treatment is to cure it. The most commonly used treatments for this ...
US Regulator Approves Eli Lilly Drug For Early Alzheimer Treatment - News18
News18· 2 days agoThe US Food and Drug Administration (FDA) approved a drug made by Eli Lilly on Tuesday that is...
Rare and fatal brain-eating amoeba infection | Explained
The Hindu· 10 hours agoA12-year-old boy, E.P. Mridul, from Feroke in Kozhikode district of Kerala, who had been undergoing ...
FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
Pharmaceutical Technology· 14 hours agoEli Lilly announced on 2 July 2024 that the US Food and Drug Administration (FDA) has approved its...
Enhancing Cancer Treatment: Pharmacogenomics Impact on Drug Response and Toxicity
SiliconIndia· 6 days agoMithun Kumar K B, Correspondent, siliconindiaPharmacogenomics has introduced a major change in the management of cancer because the genetic constitution of patients and their ...
Pune Zika Cases Rise To 8, Centre Issues Advisory To All States
NDTV· 1 day agoZika virus disease (ZVD) is a mosquito-borne disease transmitted by Aedes mosquitoes. While it is...
Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
Pharmaceutical Technology· 7 days agoEisai and Biogen have announced the introduction of LEQEMBI (lecanemab) for the treatment of...